TY - JOUR T1 - Cyclic exit strategies to suppress COVID-19 and allow economic activity JF - medRxiv DO - 10.1101/2020.04.04.20053579 SP - 2020.04.04.20053579 AU - Omer Karin AU - Yinon M. Bar-On AU - Tomer Milo AU - Itay Katzir AU - Avi Mayo AU - Yael Korem AU - Boaz Dudovich AU - Eran Yashiv AU - Amos J. Zehavi AU - Nadav Davidovitch AU - Ron Milo AU - Uri Alon Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/28/2020.04.04.20053579.abstract N2 - Many countries have applied lockdown that helped suppress COVID-19, but with devastating economic consequences. Here we propose exit strategies from lockdown that provide sustainable, albeit reduced, economic activity. We use mathematical models to show that a cyclic schedule of 4-day work and 10-day lockdown, or similar variants, can prevent resurgence of the epidemic while providing part-time employment. The cycle pushes the reproduction number R below one by reduced exposure time and by exploiting the virus latent period: those infected during work days reach peak infectiousness during lockdown days. The number of work days can be adapted in response to observations. Throughout, full epidemiological measures need to continue including hygiene, physical distancing, compartmentalization, testing and contact tracing. This conceptual framework, when combined with other interventions to control the epidemic, can offer the beginnings of predictability to many economic sectors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data supplied in the submitted file ER -